Coronavirus: Vaccination
(asked on 10th September 2020) - View Source
Question to the Department for Business, Energy and Industrial Strategy:
To ask Her Majesty's Government, further to the statement by the Secretary of State for Health and Social Care on 8 September (HC Deb, cols 517-519), what is the nature of the vaccines which form the basis of the agreements in place with six separate vaccine developers; and who are the developers.
Answered by
Lord Callanan
Parliamentary Under Secretary of State (Department for Energy Security and Net Zero)
This question was answered on 23rd September 2020
The UK has secured access to 6 different candidates, across 4 different vaccine types, reflecting the government’s strategy to ensure the UK has a supply of vaccines should any of these prove safe and effective:
- Adenoviral vaccines (University of Oxford/AstraZeneca, Janssen);
- mRNA vaccines (BioNTech/Pfizer);
- Inactivated whole virus vaccines (Valneva);
- Protein adjuvant vaccines (GlaxoSmithKline/Sanofi, Novavax).